Standard Dental Labs Inc. (OTCQB: TUTH) is a Florida-based dental laboratory consolidation company focused on building a technology-enabled network of independent dental labs. The news around TUTH highlights how the company is executing its roll-up strategy in the dental prosthetics and laboratory sector, particularly across Florida.
News coverage for Standard Dental Labs often centers on acquisition activity and integration milestones. The company has announced non-binding letters of intent with multiple Florida dental laboratories, a binding agreement to acquire Dream Dentistry Labs, LLC in Clearwater, and the acquisition of Prime Dental Labs. These updates illustrate how SDL is expanding its presence across Central Florida and assembling a connected network that links markets such as Orlando and the greater Tampa Bay area.
Investors and industry observers can also find news about SDL’s operational model and performance metrics. Through its Investor Education Series, the company has detailed how it standardizes intake, production, and quality control, routes volume through regional hubs, and tracks key indicators such as turnaround time, remake rates, gross margin expansion, digital share of cases, and technician productivity. Additional announcements discuss the company’s Regulation A qualification, capital plans to fund acquisitions and technology investments, and corporate actions such as its name and ticker changes and reverse stock split.
On this news page, readers can follow updates on Standard Dental Labs’ acquisition pipeline, integration progress, governance developments, and strategic initiatives in the dental laboratory space. For those tracking the consolidation of independent dental labs and the growth of a technology-enabled network in Florida, the TUTH news feed offers ongoing insight into how the company is advancing its stated objectives.
Standard Dental Labs (TUTH) finalized an equity purchase agreement with Twenty Four Capital for potential common stock sales of up to $10 million. SDL controls when to request purchases and how much to seek within the agreement’s limits, and is not required to sell shares. Twenty Four Capital must purchase under a qualifying notice, subject to applicable conditions.
The $10 million is the maximum aggregate gross purchase price, not funding received at signing or guaranteed proceeds. Market-based pricing, share price and trading volume affect funding availability; any shares sold would dilute holders. SDL expects to use proceeds for laboratory investments, potential acquisitions, working capital and general corporate purposes.
Standard Dental Labs (TUTH) acquired substantially all operating assets of Dr. Tooth, effective October 2, 2026, expanding its dental laboratory customer base. The business also operates as Sheen Dental Laboratory and Hansen Incarnati. The asset purchase uses cash and SDL common stock, with performance conditions tied to retained customer revenue.
Management estimates the business adds just over $800,000 in annualized revenue, taking SDL’s estimated base from approximately $822,000 to more than $1.6 million. These operating estimates extended over 12 months are not a calendar 2026 revenue forecast.
SDL plans to move production outsourced to China to Sarasota and expects improved facility profitability as integration progresses. Management sees an opportunity to rebuild the acquired business to more than $1.1 million in annualized revenue, dependent on retaining accounts, recovering customers and successfully transitioning production.
Standard Dental Labs (TUTH) filed its semiannual report; management estimates companywide annualized revenue of approximately $822,000.
First-half 2026 revenue rose to $342,634 from $163,261 a year earlier; gross profit rose to $203,718 from $78,414. Operating loss narrowed to $318,585 from $380,036, and net loss narrowed to $402,511 from $424,347. Revenue included $138,196 tied to purchased receivables for pre-acquisition BRLIT work; post-acquisition operations contributed 44 working days. The annualized estimate is 3.48 times full-year 2025 revenue of $236,234, but is not a calendar 2026 revenue forecast.
The company has five active letters of intent for potential laboratory acquisitions, subject to due diligence, definitive agreements, financing and closing conditions. It still needs capital for operations and acquisitions. It also invested in digital production at its Pine Hills laboratory and appointed Dr. David Zionts as the first member of its Board of Advisors.
Standard Dental Labs (OTCQB:TUTH) announced that its board and management have adopted a scalable capital strategy to support its ongoing dental lab acquisition program in Florida. After reviewing multiple financing options over the past year, the company created a capital framework intended to match specific financing structures to individual acquisition opportunities while preserving financial flexibility and long-term shareholder value.
Instead of relying on a single large financing event, SDL plans to deploy capital in step with acquisitions as they arise. The company continues to evaluate acquisition targets across Florida and expects this approach to aid integration into its regional hub-and-spoke operating model. Management emphasized building a durable, efficiently run company and views the framework as a milestone in supporting disciplined, long-term consolidation growth, with further details to be provided as material transactions occur.
Standard Dental Labs (OTCQB:TUTH) signed a non-binding Letter of Intent to acquire an established dental laboratory in the Tampa Bay region. The target’s identity is confidential. The deal depends on due diligence, definitive agreements, and closing conditions, and may not close.
The LOI follows last month’s acquisition of BRLIT Dental Laboratory, supporting TUTH’s strategy to build a dense Florida dental lab network focused on operational efficiency, broader services, and long-term shareholder value.
Standard Dental Labs (OTCQB: TUTH) closed its acquisition of BRLIT Dental Laboratory (effective May 6, 2026), adding approximately $886,000 of annual revenue to SDL.
Prior annual revenue of about $236,000 plus BRLIT’s contribution raises SDL’s annualized revenue base to more than $1.1 million, an increase of over 375%.
BRLIT will remain operationally integrated with key personnel retained to maintain continuity of service.
Standard Dental Labs (OTCQB: TUTH) appointed Brendan Cummins to its Board of Directors, effective April 17, 2026. Cummins brings over 35 years of capital markets and strategic growth experience, including transaction structuring, disciplined capital allocation, and operational insight.
The appointment supports the company’s acquisition-driven growth across Florida; several letters of intent are progressing toward closing, subject to customary due diligence and financing conditions.
Standard Dental Labs (OTC: TUTH) filed its 2025 Annual Report on Form 1-K and audited financials for year ended December 31, 2025, reporting corporate restructuring and the establishment of an acquisition platform.
Key 2025 milestones included an OTCQB uplisting, SEC qualification of a Regulation A offering, a 20-for-1 reverse split, restated prior financials, and a pending BRLIT asset acquisition expected to increase annualized revenue run rate by more than four times if closed by April 30, 2026.
Standard Dental Labs (OTC:TUTH) engaged EMAC Capital LLC on March 23, 2026 to provide strategic advisory services and introductions to potential funding sources for its ongoing dental lab acquisition program. The company said it intends to pursue up to $3.0 million via potential debt or equity structures. EMAC's role is advisory only; SDL retains full discretion on pursuing any funding, and EMAC will not solicit investments or receive outcome‑based compensation. No securities have been registered, and this announcement is not an offer to sell securities.
Standard Dental Labs (OTCQB: TUTH) released Part 3 of its Investor Education Series on March 6, 2026, outlining a capital allocation framework to accelerate acquisitions and integration.
The plan highlights Regulation A access to growth capital, mixed cash/stock/earn-out deal structures, acquisition criteria, integration budgets, capital priorities, and a path toward senior exchange uplisting.